A phase III, randomized, double blind, controlled trial to evaluate the efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg, compared to diclofenac 75 mg monotherapy and placebo, in the treatment of acute low back pain.

A phase III randomized double-blind trial examined whether combining intramuscular diclofenac 75 mg with thiocolchicoside 4 mg produces better outcomes than diclofenac alone or placebo in patients with acute low back pain. The study evaluated both efficacy and safety of the fixed-dose combination, providing clinical evidence relevant to pharmacological management of a condition frequently encountered in physical therapy settings. Findings from this trial may inform multimodal treatment approaches used alongside PT interventions for acute LBP.

Read full article at PubMed / Minerva Med ↗

About this summary. The text above is a short summary written for this site. The original article is hosted by PubMed / Minerva Med at the link above; this site does not reproduce the full article. Verify against the source before relying on specific details.